Compound Screening, Drugs and Fragment Screening

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

Compound Screening

Drugs

Fragment Screening

Target-directed cancer: protein-ligand interactions

Drug Target Review

NOVEMBER 1, 2023

Could you provide an overview of your research on target directed cancer drug discovery, particularly your focus on protein lagging interactions. I work in the Centre for Cancer Drug Discovery (CCDD) at The Institute of Cancer Research in London, which is an academic drug discovery centre. 2013) 56, 2059-2073.

Fragment Screening

Fragment Screening Biochemical Assays Small Molecule Biophysical Assays

Open-source Electrophilic Fragment Screening Platform to Identify Chemical Starting Points for UCHL1 Covalent Inhibitors

Covalent Modifiers

DECEMBER 3, 2024

Marto SLAS Discovery, 2024 [link] Target-based screening of covalent fragment libraries with mass spectrometry has emerged as a powerful strategy to identify chemical starting points for small molecule inhibitors or find new binding pockets on proteins of interest.

Fragment Screening

Fragment Screening Compound Screening Small Molecule Drugs

Drug Discovery Digest

Target-directed cancer: protein-ligand interactions

Open-source Electrophilic Fragment Screening Platform to Identify Chemical Starting Points for UCHL1 Covalent Inhibitors

Stay Connected